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Abstract 
We developed a Quick, Easy, Cheap, Effective, Rugged, and Safe (QuEChERS) 
method for the high throughput determination of 10 non-steroidal anti-
inflammatory drugs (NSAIDs) in milk samples using high performance liquid 
chromatography-tandem mass spectrometry (HPLC-MS/MS) with a triple 
quadrupole (QqQ) instrument and an electrospray ionization (ESI) source. The new 
extraction procedure is highly efficient, and we obtained absolute recoveries in the 
range 78.1–97.1 % for the extraction and clean-up steps. Chromatographic 
separation is performed in the gradient mode with a biphenyl column and acidic 
mobile phases consisting of water and acetonitrile containing formic acid. The 
chromatographic run time was about 12 min, and NSAID peaks showed a good 
symmetry factor. For MS/MS detection, we used multiple reaction monitoring 
(MRM) mode, using ESI in both positive and negative modes. Our method has been 
validated in compliance with the European Commission Decision 657/2002/EC, and 
we obtained very satisfactory results in inter-laboratory testing. Furthermore, we 
explored the use of a hybrid high resolution mass spectrometer, combining a 
quadrupole and an Orbitrap mass analyzer, for high resolution (HR) MS/MS 
detection of NSAIDs. We achieved lower NSAID quantification limits with Q-
Orbitrap high resolution mass spectrometry (HRMS/MS) detection than those 
achieved with the QqQ instrument; however, its main feature is its very high 
selectivity, which makes HRMS/MS particularly suitable for confirmatory analysis. 
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Introduction 
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for their anti-
inflammatory, analgesic, and antipyretic properties. The most common side effects 
of NSAIDs are related to gastric and intestinal disturbances, but allergies and other 
effects involving the hepatic, renal, hematopoietic, or central nervous systems may 
also occur [1]. 
In the European Union (EU), some NSAIDs are authorized for administration to 
food-producing animals. Since residues of these compounds in edible products are a 
potential risk to consumers, the EU has established maximum residue limits 
(MRLs) for several NSAIDs in food products of animal origin [2]. Furthermore, the 
EU Community Reference Laboratories have proposed recommended 
concentrations (RC) for NSAID without MRL, and also for diclofenac [3]. These 
RCs are guidance values that laboratories need to achieve in order to ensure 
effective control. Table 1 shows MRL and RC values for NSAIDs in milk. 
Table 1 
Maximum residue limits (MRLs) and recommended concentrations (RCs) for NSAIDs 
Compound 
MRL in milk (µg ·  kg−1) 
RC in milk (µ
Bovine Caprine 
5-Hidroxyflunixin 40     
Diclofenac 0.1   5 
Meloxicam 15 15   
Phenylbutazone     5 
Table 1 
Maximum residue limits (MRLs) and recommended concentrations (RCs) for NSAIDs 
Compound 
MRL in milk (µg ·  kg−1) 
RC in milk (µ
Bovine Caprine 
Oxyphenbutazone     5 
According to EU legislation, plans for controlling the presence of NSAID residues 
in food of animal origin are mandatory and, therefore, control laboratories require 
reliable, high throughput analytical methods. Few confirmatory methods have been 
developed for analyzing NSAID in milk samples. They are normally based on 
liquid chromatography (LC) coupled to mass spectrometry (MS), mostly using 
triple quadrupole (QqQ) instruments [4–9], although the use of high resolution 
mass spectrometry (HRMS, i.e. time of flight MS) and gas chromatography coupled 
to MS have also been described [10, 11]. 
NSAIDs are a heterogeneous group of drugs with multiple chemical structures, 
which can be classified into several groups (Table 2). This makes the development 
of NSAID multi-residue methods a challenging task, especially in terms of sample 
treatment (i.e., extraction and clean-up). 
Table 2 
Structure and molecule formulae of NSAIDs 
Few solvents have been proposed for NSAID extraction. Acetonitrile, the effect of 
which on protein precipitation facilitates efficient extraction, is the most widely 
used solvent [4–6, 11]. However, methanol [7] as well as acetonitrile/methanol [12] 
or acetonitrile/ethyl acetate mixtures [9] are also employed, and good overall 
recovery values have been reported for all systems. A controversial issue 
concerning the extraction step is the addition of ascorbic acid to prevent oxidation 
of pyrazolones (e.g., phenylbutazone and oxyphenbutazone [11, 12]. Some authors 
report that it does not improve recovery [5] and may even have a detrimental effect 
on MS detection of other analytes [7]. The use of ascorbic acid at low concentration 
levels could solve this drawback [9]. 
Since LC-MS is susceptible to matrix effects, and milk is quite a complex matrix, 
most methods include some clean-up of the extracts. Several strategies have been 
described, such as a liquid–liquid extraction with hexane to eliminate fat content 
[4, 9], but most of the methods apply solid phase extraction (SPE) with different 
sorbents, depending on the set of compounds included in the method, such as amino 
[6], octadecyl [12], or polymeric phases [5]. In general, the clean-up step is the 
bottleneck of the procedure. The methods proposed by Dubreil-Chéneau et al. [7] 
and van Pamel and Daeseleire [8] are exceptions, and no clean-up was applied after 
extraction with methanol and acetonitrile, respectively. 
LC-MS is clearly the technique of choice for confirmatory NSAID residue detection 
methods. Chromatographic separation is usually performed with octadecyl columns 
and mobile phases, mostly based on acetonitrile/water mixtures prepared at acidic 
pH. Regarding MS detection, most of the methods use a QqQ instrument with an 
ESI source, in positive or negative mode, depending on the compound. 
The overall aim of this study was to develop a reliable and straightforward 
methodology for the analysis of NSAID residues in milk that is suitable for routine 
use in laboratories with high workloads. Table 2 shows the chemical structure and 
molecular formula of the representative compounds from diverse NSAID families 
included in the present study. We present a new method based on the Quick, Easy, 
Cheap, Effective, Rugged and Safe (QuEChERS) strategy [13] and LC-QqQ-
MS/MS to analyze 10 NSAIDs in milk. We also evaluated the detection by 
HRMS/MS with a Q-Orbitrap instrument. 
Materials and methods 
Reagents 
All standards had over 98 % purity. Standards of ketoprofen (KTP), niflumic acid 
(NFL), flufenamic acid (FLF), meclofenamic acid (MEC), flunixin (FLU), 5-
hydroxy-flunixin (5-FLU), oxyphenbutazone (OPB), phenylbutazone (PBZ), 
diclofenac (DCF), and meloxicam (MLX) were obtained from Sigma-Aldrich 
(Seelze, Germany). We used meloxicam-D3 (MLX-D3), niflumic acid-13C6 (NFL-
13C6), flufenamic acid-13C6 (FLF-13C6), phenylbutazone-13C12 (PBZ-13C12), also from 
Sigma-Aldrich, as internal standards (ISs). Acetonitrile and methanol (HPLC 
quality) were obtained from Panreac (Barcelona, Spain). Acetonitrile of hypergrade 
quality was obtained from Merck Millipore (Darmstadt, Germany). Double 
deionized water of 18.2 MΩ ·  cm−1 was obtained from a Milli-Q system (Millipore, 
Billerica, MA, USA). Other chemicals were of analytical reagent grade. Acetic acid 
and anhydrous sodium sulfate were obtained from Panreac. Ammonium acetate, 
ascorbic acid, and magnesium sulfate were obtained from Merck Millipore. Formic 
acid was obtained from Sigma-Aldrich (Seelze, Germany). Hydrochloric acid 
(32 %) was obtained from Fisher Chemical (Boston, MA, USA). Lichroprep RP-18 
(25–40 µm) was obtained from Merck Millipore, and Bondesil primary-secondary 
amines (PSA) 40–100 µm was obtained from Agilent Technologies, (New Castle, 
DE, USA); 0.22 µm nylon membrane filters were obtained from Merck Millipore. 
Standard solutions were prepared as follows: individual stock solutions 
(1000 mg ·  L−1): 10 mg of each compound was weighed and dissolved in 10 mL of 
methanol using volumetric flasks, and stored at −18 °C for up to 1 y. An 
intermediate standard solution at a concentration of 20 mg ·  L−1 was prepared in 
methanol and stored for up to 6 mo at −18 °C. Working solutions at concentrations 
of 5, 2, and 0.4 mg ·  L−1 of each analyte were prepared in 0.1 % formic acid in 
ultrapure water and stored for up to 3 mo at −18 °C. 
IS solutions were prepared in the same way as the stock standard solutions. The 
working solution had a concentration of 20 mg ·  L−1. 
Solutions of ascorbic acid 0.02 M, hydrochloric acid 0.24 M, and formic acid 0.1 % 
were prepared using double deionized water as solvent. 
Instrumentation 
For sample preparation, we used a multi-tube vortex (VWR, DVX-2500), a 
laboratory centrifuge HettichRotanta 460R (Tuttlingen, Germany), a vertical 
agitator Agitax (Cisco Systems, Spain), a Turbovap nitrogen evaporator from 
Biotage (Uppsala, Sweden), and an ultrasonic bath (Ultrasons-H) from Selecta 
(Barcelona, Spain). 
LC-QqQ-MS/MS 
The LC system consisted of an Agilent Technologies 1290 coupled to an Agilent 
QqQ 6460 mass spectrometer with electrospray ionization (ESI), used in both 
positive and negative modes. The ESI source was operated under the following 
conditions: capillary voltage: −3.0 kV (ESI–) and 3.5 kV (ESI+); sheath gas 
temperature: 375 °C; gas temperature: 180 °C; gas flow (N2): 5 L ·  min−1, sheath gas 
flow (N2): 11 L ·  min−1; nebulizer gas (N2) pressure: 45 psi. Nitrogen was obtained 
from a Peek nitrogen generator (Air Liquid, Paris, France). Instrument control and 
data processing were carried out using Masshunter B.07.00 software. 
A gradient using 0.1 % formic acid in water (mobile phase A) and 0.1 % formic 
acid in acetonitrile (mobile phase B) at a flow of 0.4 mL/min was used to separate 
the NSAIDs on a Phenomenex Kinetex Biphenyl column (2.6 µm, 100 × 2.1 mm); 
the column temperature was kept at 40 °C and the injection volume was 20 µL. The 
gradient program was the following: (time, %A): (0, 90), (10, 45), (10.1, 90), (14, 
90). The total runtime was 14 min. 
We monitored two transitions per compound and one transition for the internal 
standards. Table 3 shows the MS/MS parameters for each compound. 
Table 3 
Optimized MS parameters for QqQ and Q-Orbitrap 
Analyte 
QqQ 
ESI+/ESI- Rt (min) 
Precursor 
ion (m/z) 
Fragmentor 
energy(V) 
Product 
ion 1 
(m/z) 
CE 
(V) 
Product 
ion 2 
(m/z) 
CE 
(V) HESI+/HESI
KTP ESI+ 7.11 254.8 130 105 15 77 50 HESI+ 
NFL ESI– 7.39 280.6 130 176.8 15 237 35 HESI- 
FLF ESI– 9.32 280.0 130 236.0 25 215.0 15 HESI- 
MEC ESI+ 5.89 296.7 110 278.9 15 263.8 40 HESI- 
FLU ESI– 5.89 294.5 70 251 15 208.9 35 HESI- 
5-FLU ESI+ 5.49 312.7 110 295 25 279.9 35 HESI- 
OPB ESI– 7.29 323.0 130 295 15 134 15 HESI- 
PBZ ESI– 9.47 307.0 130 279.1 15 131 15 HESI- 
DCF ESI– 8.84 293.8 90 250.1 10 293.8 -- HESI- 
MLX ESI+ 7.51 351.6 130 115 15 141 25 HESI+ 
MLX-
D3 
ESI+ 7.49 354.6 130 115 15 --- --- HESI+ 
NFL 13C6 ESI- 7.39 287.8 130 270 25 --- --- HESI- 
FLF 13C6 ESI- 9.324 286.1 130 242.1 15 --- --- HESI- 
PBZ13C12 ESI- 9.53 320.8 130 166.1 25 ---- --- HESI- 
CE collision energy, NCE normalized collision energy, In bold quantitation product ion 
LC-Q-Orbitrap-HRMS/MS 
The HRMS instrument was a hybrid Q-Exactive from Thermo Scientific (Bremen, 
Germany). A Thermo Accela UHPLC system coupled to a Maylab Switch column 
manager and to the Q-Exactive mass spectrometer was used. The chromatographic 
system was coupled to the MS with a heated electrospray ionization source II 
(HESI II). HESI II conditions were: spray voltage +3.5 kV (positive ionization) or 
−3 kV (negative ionization); sheath gas flow rate (N2), 35 (arbitrary units); capillary 
temperature, 300 °C; S-lens rf level, 50; heater temperature, 350 °C. Nitrogen 
obtained from a nitrogen generator Zefiro (Clantecnologica, Seville, Spain) was 
employed as both the collision and damping gas. 
Mass calibration for Orbitrap was performed daily to ensure a working mass 
accuracy lower than or equal to 5 ppm. Pierce LTQ Velos ESI Positive ion and 
Pierce LTQ Velos ESI Negative ion calibration solutions (Thermo Fisher Scientific, 
Rockford, IL, USA) were used to calibrate the mass spectrometer. The resolution 
was set at 70,000 (m/z 200, FWHM) at a scan rate of 2 Hz, and the automatic gain 
control (AGC) was set at 2e5 with a maximum injection time set at 100 ms. 
Xcalibur 2.2 and Trace Finder 3.2 (Thermo Fisher Scientific, San Jose, CA, USA) 
were used for LC-HRMS control and data processing, respectively. 
A gradient using aqueous 0.1 % formic acid (mobile phase A) and acetonitrile 
hypergrade with 0.1 % formic acid (mobile phase B) at a flow of 0.3 mL ·  min−1 was 
used to separate the NSAIDs on a Phenomenex Kinetex XB C18 column (1.7 µm, 
100 × 2.1 mm); the column temperature was kept at 40 °C and the injection volume 
was 10 µL. The gradient program was as follows; (time, %A): (0, 70), (10, 45), 
(10.1, 70), (12, 70). Total runtime was 12 min. 
Specific detection conditions when using HRMS are given in Table 3. 
Sample treatment 
Five g of milk sample was weighed in a centrifuge tube and 100 µL of a 
20 mg ·  L−1 solution of IS was added. Subsequently, 10 mL of 5 % acetic acid in 
ACN, 1 g of ammonium acetate, 4 mL of ascorbic acid 0.02 M in HCl 0.24 M and 
5 g of Na2SO4were added. The sample was shaken for 5 min using multi-tube 
vertical shaker, sonicated for 5 min and subsequently centrifuged (3000 rpm, 10 °C, 
10 min). The supernatant was transferred to a centrifuge tube containing 150 mg of 
C18 and 1 g of MgSO4 and the mixture was shaken for 5 min (vortex), sonicated for 
5 min, and centrifuged under the aforementioned conditions. Then, the supernatant 
was evaporated to around 250 µL under a N2 stream at 40 °C, diluted to 500 µL 
with 0.1 % formic acid and filtered through a 0.22 µm nylon filter membrane. 
Calibration 
The quantification of NSAIDs in milk samples was based on the use of surrogate 
matrix matched standards (SMMS). SMMSs consisted of blank milk samples spiked 
with known amounts of NSAIDs and 100 µL of IS. After spiking, SMMSs were left 
for contact during 30 min before proceeding to the extraction, according to the 
extraction protocol described above. Linear regression was performed by plotting 
the peak area ratio of the analyte to IS against the analyte concentration. ISs were 
assigned to analytes as follows: MLX-D3 for MLX, DCF, and KTP, NFL-13C6 for 
NFL and MEC, FLF-13C6 for FLF, 5-FLU, FLU, and PBZ-13C12 for PBZ and OPB. 
Calibration with SMMS provides quantification of the sample automatically 
corrected by the recovery value. 
Results and discussion 
Method development 
LC-QqQ-MS/MS 
The multiple reaction monitoring (MRM) mode was used for quantification and 
confirmation. Thus, to optimize MS detection and select precursor and product ions 
for each analyte, standard solutions of 5 mg ·  L−1 in methanol were infused into the 
mass spectrometer, and spectra were acquired using the ESI source operating in 
positive or negative mode. The mobile phase consisted of water:acetonitrile (1:1). 
The “Fragmentor” parameter was optimized in the 70–130 V range to obtain 
maximum response for precursor ions. Collision energy was optimized in the range 
5–35 V to obtain maximum response for the product ions. The final selection of ESI 
polarity and MRM transitions for each NSAID was based on both sensitivity and 
selectivity criteria. The mass spectrometer was quick enough to switch polarity 
without compromising sensitivity. Two transitions of the precursor ion were 
selected to achieve enough identification points to confirm the identity of the 
analytes (Table 3). The most intense transition (in bold) was used for 
quantification, and the ion ratio parameter for confirmation. 
Although MS detection is a selective technique, good chromatographic separation is 
advisable. The chromatographic separation of NSAIDs is usually performed in 
reversed mode on C8 or C18 columns. In this study, we assayed two 
chromatographic columns (Kinetex XB C18, 1.7 µm and Kinetex biphenyl, 2.1 µm, 
both solid core type). The biphenyl stationary phase behaves similarly to C18 but 
with enhanced aromatic selectivity, so that deeper interaction with the aromatic 
rings of the analytes is achieved. We used mobile phases based on water-
acetonitrile mixtures and tested several gradient programs at 0.4 mL ·  min−1, starting 
at 10 % to 40 % acetonitrile and reaching 55 % acetonitrile in 6 to 10 min. 
We observed some changes in the elution order between the columns: C18 column, 
MLX, 5-FLU, KTP, MEC, FLU, FLF, NFL, OPB, DCF, and PBZ; biphenyl 
column, 5-FLU, MEC, FLU, KTP, OPB, NFL, MLX, DCF, FLF, and PBZ. Some 
overlapping peaks were obtained with both columns, but the NSAID peaks obtained 
with the biphenyl column showed a better symmetry factor than those obtained with 
the C18 column and, thus, the biphenyl column was selected for further assays. 
When injecting milk extracts, NSAID retention times showed poor reproducibility 
when comparing injections of standards in solvent and standards in extracted 
matrix. Adding formic acid to the mobile phase resolved this issue, leading to 
reproducible retention times. The addition of acidic media did not result in loss of 
sensitivity for the compounds monitored in negative mode. After adjusting gradient 
conditions for the biphenyl phase (described in the Materials and methods Section), 
we achieved good chromatographic separation in a total run time of 14 min, 
including equilibration time (Fig. 1). 
Fig. 1 
LC-QqQ-MS/MS chromatograms of a standard mixture of 0.4 mg ·  L−1 of NSAIDs and 
internal standards 
Extraction method 
Various approaches have been proposed for extracting NSAIDs from milk samples. 
Acetonitrile has been found to provide efficient extraction and quite clean extracts 
because of its deproteinizing effect. Methanol is less commonly used, but is also 
effective. Regardless, most methods include a clean-up step, based on either solid 
phase extraction or liquid–liquid extraction with hexane, or a combination of both, 
before the chromatographic analysis. The aim of this study was to develop a simple 
but reliable extraction method, suitable for laboratories with high workloads. 
Thus, we carried out preliminary studies using the QuEChERS approach, and also 
applied the methods proposed by Jedziniak et al. [6] (extraction with acetonitrile 
containing ammonia and clean-up by SPE with amino cartridge), and by Moragues 
et al. [14] (extraction with methanol and clean-up by SPE with C18 cartridge). In 
the QuEChERS assays, the extraction step was based on acetonitrile containing 5 % 
acetic acid to ensure protonation of carboxylic acids. We also added sodium 
chloride and magnesium sulfate. After shaking and centrifugation, the organic layer 
underwent a clean-up step by dispersive solid phase extraction (d-SPE) with C18. 
We analyzed the extracts by LC-QqQ-MS/MS, and compared NSAID peak areas 
using the three methodologies. Overall, none of the methods assayed provided 
optimal results for all compounds, but yielded similar results when compared 
globally. Thus, the simplicity and speed of the QuEChERS methodology was a 
significant differentiating factor, so we focused our efforts on optimizing a new 
method based on this approach. 
We compared two distinct dispersive media for the d-SPE step, C18 and PSA, and 
found better recoveries for the majority of analytes when using C18 (see Electronic 
Supplementary Material (ESM) Fig. S1). We also investigated to omit the clean-up 
step in order to speed up the analysis, but we obtained unsatisfactory results, with 
low signals for almost all analytes (see ESM Fig. S1) 
Although the results achieved using the QuEChERS approach were satisfactory 
overall, MS signals for PBZ and OPB were low and poorly reproducible, both with 
C18 and PSA. These compounds may readily undergo oxidation, and the addition of 
ascorbic acid to prevent their oxidation has been proposed. However, this 
antioxidant reagent may have deleterious effects on MS/MS detection of NSAIDs 
[7], which can be prevented by using a relatively low concentration of ascorbic acid 
[9]. Adding 0.006 M ascorbic acid to the acetonitrile extraction solution markedly 
improved the results of PBZ and OPB, and with no relevant adverse effects on the 
signals of other NSAIDs. 
Finally, we substituted sodium chloride with ammonium acetate in the extraction 
solution, and obtained lower baseline noises, thus allowing lower detection limits. 
The final conditions adopted for the QuEChERS extraction and clean-up by d-SPE 
with C18 are reported in the Sample treatment Section. The absolute recoveries for 
the QuEChERS method obtained at 2.5 µg ·  kg−1 are shown in Fig. S2 (ESM). These 
results, in the 78-96 % range, are very satisfactory, making this a suitable and 
simple new method for routine laboratory testing. 
Method validation 
We validated the QuEChERS LC-QqQ-MS/MS method in milk according to the 
European Commission Decision 657/2002/EC guidelines [15], and tested the 
following parameters: linearity, extraction recovery, intermediate precision, 
trueness, selectivity, ruggedness, limit of decision (CCα), and detection capability 
(CCβ). 
Linearity 
We built calibration curves for each compound using SMMS in the 2.5–
25 µg ·  kg−1 range, except for FLU, for which calibration curves reached 
60 µg ·  kg−1. We used the correlation coefficient and point-to-point deviation (in %, 
with respect to the theoretical value) to evaluate linearity, and obtained good 
linearity for all analytes: correlation coefficients >0.99 for all the compounds 
except for ketoprofen, which showed correlation coefficient >0.95. Residuals were 
always <25 % at the lowest concentration (2.5 µg ·  kg−1) and <15 % for higher 
calibration concentrations. 
Extraction recovery 
Before extraction, we spiked a set of blank samples in the range 2.5–
40 µg ·  kg−1 and extracted. Then, we extracted and spiked a second set of blank 
samples after extraction and clean-up, and calculated absolute recovery for sample 
treatment steps by comparing the results. The experiment was repeated three times 
on three different days. Absolute recoveries for the extraction and clean-up steps 
ranged from 78.1 to 97.1 % (Table 4). 
Table 4 
Validation results in milk 
Analyte Concentration (µg ·  kg−1) 
Extraction recovery (%) 
(n = 3) 
Precision (RSD%) 
(n = 18) 
Trueness (%)
(n = 18)
KTP 
2.5 81.0 10.4 87.6 
5.0 95.6 12.0 97.8 
Table 4 
Validation results in milk 
Analyte Concentration (µg ·  kg−1) 
Extraction recovery (%) 
(n = 3) 
Precision (RSD%) 
(n = 18) 
Trueness (%)
(n = 18)
10.0 92.2 10.7 98.8 
25.0 87.5 8.6 103.1 
NFL 
2.5 93.4 9.2 108.4 
5.0 90.6 7.8 107.4 
10.0 93.4 10.1 94.0 
25.0 93.9 10.1 100.8 
FLF 
2.5 96.0 10.3 108.8 
5.0 90.9 7.9 108.0 
10.0 96.5 8.3 95.5 
25.0 91.9 9.4 101.2 
MEC 
2.5 91.2 10.8 105.6 
5.0 90.4 10.4 102.8 
10.0 93.3 10.4 84.1 
25.0 95.3 12.2 94.1 
FLU 
2.5 92.9 10.3 97.6 
5.0 90.2 13.5 94.6 
10.0 95.2 7.9 105.1 
25.0 89.3 10.8 102.3 
Table 4 
Validation results in milk 
Analyte Concentration (µg ·  kg−1) 
Extraction recovery (%) 
(n = 3) 
Precision (RSD%) 
(n = 18) 
Trueness (%)
(n = 18)
5-FLU 
2.5 89.7 14.3 91.2 
5.0 87.1 9.7 103.8 
10.0 88.2 11.5 85.7 
25.0 88.2 10.0 101.1 
40.0 88.3 1.7 101.9 
DCF 
2.5 92.3 9.2 92.4 
5.0 91.0 8.8 100.0 
10.0 97.1 12.8 102.0 
25.0 90.9 12.2 90.8 
DCF 
2.5 92.3 9.2 92.4 
5.0 91.0 8.8 100.0 
10.0 97.1 12.8 102.0 
25.0 90.9 12.2 90.8 
OPB 
2.5 94.7 11.7 103.2 
5.0 89.3 13.1 94.6 
10.0 91.1 12.2 98.8 
25.0 85.6 13.7 100.7 
PBZ 2.5 78.1 16.9 98.8 
Table 4 
Validation results in milk 
Analyte Concentration (µg ·  kg−1) 
Extraction recovery (%) 
(n = 3) 
Precision (RSD%) 
(n = 18) 
Trueness (%)
(n = 18)
5.0 89.1 12.6 101.8 
10.0 95.3 11.8 99.1 
25.0 86.1 14.9 88.9 
MLX 
2.5 94.4 15.2 98.0 
5.0 92.5 9.0 102.8 
10.0 92.0 7.8 102.0 
15.0 91.2 3.0 103.1 
25.0 90.5 12.2 104.3 
Intermediate precision 
The study was performed at four concentration levels over 3 d, with six spiked 
samples analyzed daily at each concentration level. Results were evaluated in terms 
of relative standard deviation (%RSD), which ranged from 1.7 to16.9 %, and were 
always below the value calculated by the Horwitz equation. 
Trueness 
There is no certified material available for determining trueness, so we used the 
spiked samples approach. We compared the concentrations obtained for the spiked 
blank samples with the theoretical values from a SMMS calibration curve, 
expressed in %, and obtained good results, ranging from 84.1 to 108.8 % (Table 4). 
Selectivity 
We evaluated this parameter by analyzing different blank samples, and in all cases 
we observed no interferences at the retention time of the analytes. In addition, we 
found no relevant differences between the IS responses in all blank samples, with 
%RSD below 20 %. 
Ruggedness 
We evaluated critical steps of the method by introducing minor changes and 
evaluating the results. The parameters evaluated were the use of different samples, 
the effect of drying on the extracts, and the effect of the evaporation temperature. 
Moreover, the use of different instruments (vertical agitators and evaporators) was 
considered. Different operators carried out the experiments. No significant 
differences were found for the studied parameters, except for the evaporation step: 
when reaching dryness of the extracts, we obtained low responses for KTP, OPB, 
and PBZ. 
CCα and CCβ 
MRL has only been established in milk for three of the studied compounds, namely 
FLU (expressed as 5-FLU), MLX, and DCF. For MLX and 5-FLU, CCα and CCβ 
were determined around these limits as described in [15], and results are shown in 
Table 4. However, for DCF, the MRL has been set at such a low concentration 
(0.1 µg ·  kg−1) that the method was not suitable. In fact, very few methods have 
reported in the literature as being able to confirm the presence of DCF at 
0.1 µg ·  kg−1 [6, 8,9]. 
We proceeded with DCF as for NSAIDs with no published MRL, with CCα and 
CCβ were established at the lowest possible concentration level. Thus, we 
determined CCα and CCβ by extrapolating the calibration curve as described in 
2002/657/EC Commission Decision [15], based on the ISO/IEC 11843–2 standard 
regulation [16]. In the present study, the SMMS calibration curves ranged from 2.5 
to 25 µg ·  kg−1. Results for CCα and CCβ ranged from 0.4 to 1.5 µg ·  kg−1 for CCα 
and from 0.8 to 1.9 µg ·  kg−1 for CCβ (Table 4). 
To assess the performance of the method and the consistency of the calculated CCα, 
blank milk samples were spiked at 0.5, 1, and 1.5 µg ·  kg−1 and analyzed using the 
new method. The NSAIDs were detected in all cases. 
Furthermore, we participated in the inter-laboratory exercise Fapas number 02274 
(NSAIDs in bovine milk), with very satisfactory results: the sample contained 
7 µg ·  kg−1 of PBZ and a Z-score = 0 was obtained, proving the suitability of the 
proposed method. 
Analysis of NSAIDs in milk by UHPLC-Q-Orbitrap-HRMS/MS 
The new generation of HRMS instruments, such as Orbitrap-based mass 
spectrometers, are a powerful tool for enhancing the selectivity of analytical 
methods because of their high resolution power and sensitivity. In the food safety 
field, approaches using these types of instruments are increasingly being used to 
confirm the results of low resolution mass spectrometers (LRMS), and also as a tool 
for routine analysis. They seem especially suited for highly demanding scenarios, 
such as the analysis of DCF in milk, because of its very low MRL (0.1 µg ·  kg−1). 
We used a hybrid Q-Orbitrap instrument coupled to a UHPLC system. The 
chromatographic separation of NSAIDs was performed in the gradient elution mode 
on a Kinetex XB C18 column as described in the Materials and methods Section. 
Total run time was 15 min and retention times for NSAIDs ranged between 5.6 and 
11 min. 
Standards of 1 mg ·  L−1 were injected into the UHPLC-Q-Orbitrap system to 
optimize the analytical response, for both precursor and product ions of NSAIDs. 
The working mode was product reaction monitoring (PRM) with a mass width for 
the precursor ion selection set at 1 Da and resolution set at 70,000 (m/z 200, 
FWHM). We selected mild conditions for collision energy, allowing both precursor 
and product ion monitoring, and operational parameters were optimized (shown in 
theMaterials and methods Section). Comparing QqQ and Q-Orbitrap spectrometer 
working conditions, some compounds differ in polarity (i.e., MEC and 5-FLU). The 
majority of NSAIDs ionize in both positive and negative mode, and our criterion 
was to select conditions that provided the optimal response for each instrument to 
achieve the lowest concentrations. 
Following chromatographic and MS optimization, we injected extracted milk 
samples to test the performance of the method. We analyzed SMMSs in the 
concentration range 2.5–40 µg ·  kg−1 and obtained good linearity, with correlation 
factors higher than 0.99. All NSAIDs were detected and confirmed at the lowest 
calibration level. 
Finally, we tested the performance of the UHPLC-HRMS/MS system at sub-
µg ·  kg−1 level. For this purpose, blank milk samples were spiked with NSAIDs at 1, 
0.7, 0.5, 0.3, 0.1, and 0.05 µg ·  kg−1. All NSAIDs were detected at 1 and 
0.7 µg ·  kg−1(both precursor and product ions were present); precursor ions were 
detectable at lower concentrations, even at 0.1 µg ·  kg−1, except for MEC. However, 
confirmation at this level was only possible for KTP, NFL, FLF, FLU, 5-FLU, 
OPB, DCF, and MLX (Fig. 2). These results show that confirmatory analysis of 
DCF is possible at the MRL level. The mass accuracy was below 5 ppm in all cases. 
Figure 2 shows the chromatograms of NSAID precursor ions from a milk sample 
spiked at 0.5 µg ·  kg−1 (a) and at 0.1 µg ·  kg−1 (b). 
Fig. 2 
LC-HRMS/MS chromatograms of precursor ions. Milk samples spiked 
at: (a) 0.5 µg ·  kg−1; (b) 0.1 µg ·  kg−1 
 
Conclusions 
The QuEChERS methodology has proven to be a reliable strategy for analyzing 
NSAIDs in milk samples using LC-MS/MS. The new method allows high sample 
throughput thanks to its simplicity and effectiveness, and is very suitable for 
control laboratories. The method has been validated, and its successful performance 
in proficiency tests demonstrates its ability to provide accurate results. 
We have also investigated the use of HRMS/MS. The high accuracy, resolution, and 
sensitivity provided by the Q-Orbitrap instrument is especially suitable for reliable 
analysis at very low concentrations, such as that required for diclofenac, the MRL 
of which is established by EU legislation at 0.1 µg ·  kg−1. Although this 
instrumentation still has a limited presence in food safety testing laboratories, it is 
useful for routine analysis and may become an excellent tool for complex samples, 
and an alternative to triple quadrupole mass spectrometers. 
The new method is currently used in control plans implemented in the area of 
Catalonia, and was used to analyze more than 50 samples of milk from different 
animal species in 2015. 
Acknowledgments 
The authors thank Jojo Tibon for his contribution to the HRMS experiments. 
Compliance with ethical standards 
Conflict of interest 
  
The authors declare that they have no conflict of interest. 
Electronic supplementary material 
Below is the link to the electronic supplementary material. 
ESM 1 
(PDF 429 kb) 
References 
1.  
Sweetman SC, editor. Martindale. The Complete Drug Reference. 37th ed. London: 
Pharmaceutical Press: Royal Pharmaceutical Society; 2011. 
2.  
Commission Regulation (EU) Nr. 37/2010 of 22 December 2009 on 
pharmacologically active substances and their classification regarding maximum 
residue limits in foodstuffs of animal origin. Off J Eur Union. 2009; L 15/1. 
3.  
CRL Guidance Paper. CRL’s View on the art of Analytical Methods for National 
residue control Plans. 2007. Available 
at:http://www.bvl.bund.de/SharedDocs/Downloads/09_Untersuchungen/EURL_Em
pfehlungen_Konzentrationsauswahl_Methodenvalierungen_EN.pdf;jsessionid=75F
6F1917236B2A4DBCF5145859A6C22.2_cid332?__blob=publicationFile&v=2http:
//www.bvl.bund.de/SharedDocs/Downloads/09_Untersuchungen/EURL_Empfehlun
gen_Konzentrationsauswahl_Methodenvalierungen_EN.pdf?__blob=publicationFile
&v=2 . Accessed 29 Feb 2016. 
 
4.  
Malone EM, Dowling G, Elliot CT, Kennedy DG, Regan L. Development of a 
rapid, multiclass method for the confirmatory analysis of anti-inflammatory drugs 
in bovine milk using liquid chromatography tandem mass spectrometry. J 
Chromatogr A. 2009;1216:8132–40. 
5.  
Gentili A, Caretti F, Bellante S, Mainero Rocca L, Curini R, Venditti A. 
Development and validation of two multiresidue liquid chromatography tandem 
mass spectrometry methods based on a versatile extraction procedure for isolating 
non-steroidal anti-inflammatory drugs from bovine milk and muscle tissue. Anal 
Bioanal Chem. 2012;404:1375–88. 
6.  
Jedziniak P, Szprengier-Juszkiewicz T, Pietruk K, Sledzinska E, Zumdzki. 
Determination of non-steroidal anti-inflammatory drugs and their metabolites in 
milk by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 
2012;403:2955–63. 
 
7.  
Dubreil-Chéneau E, Pirotais Y, Bessiral M, Roudaut B, Verdon E. Development 
and validation of a confirmatory method for the determination of 12 anti-
inflammatory drugs in milk using liquid chromatography-tandem mass 
spectrometry. J Chromatogr A. 2011;1218:6292–301. 
8.  
Van Pamel E, Daeseleire E. A multiresidue liquid chromatographic tandem mass 
spectrometric method for the detection and quantitation of 15 non-steroidal anti-
inflammatory drugs (NSAIDs) in bovine meat and milk. Anal Bioanal Chem. 
2015;407:4485–94. 
9.  
Peng T, Zhu AL, Zhou YN, et al. Development of a simple method for 
simultaneous determination of nine subclasses of non-steroidal anti-inflammatory 
drugs in milk and dairy products by ultra-performance liquid chromatography with 
tandem mass spectrometry. J Chromatogr B. 2013;933:15–23. 
10.  
Stolker AAM, Rutgers P, Oosterink E, et al. Comprehensive screening and 
quantification of veterinary drugs in milk using UPLC-ToF-MS. Anal Bioanal 
Chem. 2008;391:2309–22. 
11.  
Dowling G, Gallo P, Fabroccino S, Serpe L, Regan L. Determination of ibuprofen, 
ketoprofen, diclofenac, and phenylbutazone in bovine milk by gas chromatography 
tandem mass spectrometry. Food Addit Contam Part A. 2008;25:1497–508. 
12.  
Gallo P, Fabroccino S, Vinci F, Fiori M, Danese V, Serpe L. Confirmatory 
identification of sixteen non-steroidal anti-inflammatory drug residues in raw milk 
by liquid chromatography coupled with ion trap mass spectrometry. Rapid Commun 
Mass Spectrom. 2008;22:841–54. 
13.  
Anastassiades M, Lehotay SJ, Stajnbaher D, Schenck FJ. Fast and easy multiresidue 
method employing acetonitrile extraction/ partitioning and dispersive solid-phase 
extraction for the determination of pesticide residues in procedure. J AOAC Int. 
2003;86:412–43. 
14.  
Moragues F, Igualada C, León N. Qualitative confirmatory method for 
determination of Phenylbutazone and 11 prohibited NSAIDs in animal tissue and 
milk by UPLC-MS/MS. Prague: Recent Advances in Food Analysis; 2013. 
15.  
Commission Decision 2002/657/EC of 12 August 2002 implementing Council 
Directive 96/23/EC concerning the performance of analytical methods and the 
interpretation of results. Off J Eur Union. 2002; L 221/8–36. 
16.  
ISO 11843–2. Capability of detection. Part 2: Methodology in the linear calibration 
case. 2nd ed. International Organization for Standardization; 2000. 
 
